Tag: FATE

Blue Horseshoe Stocks: SVSN Review & More

Stereo Vision Entertainment, Inc. SVSN

It was roughly six weeks back that we put SVSN on our radars on a routine news scan, and as we always say, it’s better to be early to the party than late. All the way up until last week, the stock wasn’t trading with any real vigor, but things have picked in a huge way, both in volume and price.

From its low at .08 at the beginning of last week, the stock finished out at a high of .89, for an intraweek rip of 1012% This came on the news that the company will file a $50M Real Estate Investment Trust on behalf of its CannaVision subsidiary, with the goal of organically growing cannabis for the purposes of extracting CBD.

Progressive Care, Inc. RXMD

We also want to swing back around to RXMD this morning, which we intially tagged onthe morning of February 22nd. Since that time the stock has exhibited a fairly steady climb up the chart.

We observed a low of .0663 in RXMD on that first day, and as of Friday’s new high of .129, we had watched as the stock rose 95% over a period of just seven trading sessions. It’s streaking to its highest PPS in nearly five years, so it’s safe to say RXMD is in blue sky breakout territory, and we’ll be eager to continue tracking its movements.


Fate Therapeutics, Inc. FATE

We also wanted to recap the solid move we’ve witnessed in FATE, since mentioning the stock toward the end of January. It dipped slightly to a low of 6.76 shortly thereafter, and has since gone a very impressive run.

The stock reached a new high of 14.02 on Friday, which worked out to a 108% upswing in a matter of less than a month.

Extended Watchlist:
RJDG, ATNM, INPX, NSPR, GNL, OTIV, CLSD, MYSZ

Blue Horseshoe Stocks: NFLX Options & More

Sorrento Therapeutics, Inc. SRNE

Recently we’ve been delving back into our reports from late 2017, to review the ones that have made notable moves, and next up on the list SRNE.

We last signaled our interest in this as a bottom-watch play back on November 16th, and while it took a couple weeks for it to get out of its sideways-trading funk, the beginning of December brought the start of a fantastic run from an ultimate low of 2.15 that has persisted into the present. Yesterday the stock reached a new annual high of 8.05 (highest PPS since October ’16), marking an increase of 274%

This most recent push in what has definitely been a steady but sharp rise of the past six weeks may have been helped along by Celgene’s (CELG) buyout of Juno Therapeutics (JUNO), which share a market space with SRNE. The company also has some promising treatments in its pipeline.

Volume has recently been ramping up in a big way, too, so we’ll definitely continue to have an eye on this stock’s activity.

Netflix, Inc. NFLX – Options Idea

We’re always looking for a good opportunity to make some quick gains in the wake of a big company’s earnings, and NFLX is one that we’ve had quite a bit of experience with in that arena.

That’s why we’re going to enter an idea into the log this morning in the NFLX Weekly $247.50-255 Calls as the company posted a promising report including the addition of more than eight million new subscribers even despite its recent price increases.

Shares of NFLX broke a double top and are in blue skies, hitting a new all time high, so we’re very interested to track the ideas we’ve identified. They may be able to furnish us with some impressive gains.

Extended Watchlist:
CNET, ROKU, FATE, RMD, FNJN, VYGR

Blue Horseshoe Stocks: ICLD, CATB Recaps & More

Intercloud Systems, Inc. ICLD

We caught ICLD coming off of its bottom, and tagged the stock in our report from two Thursday’s ago on the 2nd. Subsequent to that, we would witness a low of .0157 in the stock, and since then it has been one big bullish run that led to an impressive new high on Friday.

We’ve stayed with it each step of the way as it rose from that .0157 low to Friday’s top mark of .0465. That works out to a fantastic move of 196% which occurred over a period of just seven trading sessions.

The sheer amount of activity in the stock on Friday, with more than $6M worth of ICLD shares changing hands, coupled with the strong close has us very interested to track its movements as it leaves the starting gate this morning.

We also prepared a video presentation of the ICLD Chart and its recent movements that you can view by clicking the graphic below:

Catabasis Pharmaceuticals, Inc. CATB

Speaking of catching plays coming off of their bottoms, we signaled CATB in Friday’s premarket report, noting the monster gap on its chart to the upside.

We highlighted this one just in the nick of time, as the move it made during Friday’s session ultimately provided for the filling of around three quarters of that gap. CATB ran from a low of 1.58 and went on to hit a high of 2.76, for a very respectable intraday pop of 75%

In terms of what we want to see moving forward, we’ll be looking for CATB to maintain a level of support each day higher than the previous session.

Side Note: These two winners (ICLD, CATB) from Friday’s report also happened to turn in the two top-gaining performances for the entire NASDAQ exchange for Friday’s session!


Aviragen Therapuetics, Inc. AVIR

We also want to issue a quick alert on yet another potential bottom play that appears to be perfectly primed for a rebound. As you can see plainly on the chart snapshot below, there is a sizable gap to fill to the upside, and our favorite indicators are screaming ‘bullish’ at this point.

The chances of seeing a rebound out of AVIR sooner rather than later seem quite good as we kick off another trading week.

Extended Watchlist:
CBR, FATE, TENX
CETX, ORPN (Bottom-Bouncers)